Skip to main content
ResearchTreatments

New Clinical Trial: Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform..

By January 6, 2021February 26th, 2021No Comments

*November 2020*

This new clinical trial is for those people whose EGFR lung cancer has transformed to small cell lung cancer.This trial covers travel expenses as well. Any questions can be directed to Dr. Anish Thomas at: Anish.Thomas@nci.gov. (In addition to this trial, there are other NCI trials for small cell lung cancer that patients with transformation could qualify for.)  Learn more about this clinical trial.